주요성과

• 논문 목록
  • 2024년
  • 2023년
  • 2022년
  • 2021년

  해당 관련 논문목록과 초록보기 링크 제공

  Artificail intelligence-based radiographic extent analysis to predict tuberculosis treatment outcomes: a multicenter cohort study(Scientific Reports,2024)

  초록보기

  해당 관련 논문목록과 초록보기 링크 제공

  Molecular analysis of the anti-tuberculosis drug resistance of Mycobacterium tuberculosis isolated in the Republic of Korea(Antibiotics,2023)	초록보기
  Whole genome sequencing of Mycobacterium tuberculosis isolated before and after treatment(Microbiology Resource Announcements,2023)	초록보기
  Whole genome sequencing of Mycobacterium tuberculosis isolated from three hospitals in south Korea(Microbiology Resource Announcements,2023)	초록보기

  해당 관련 논문목록과 초록보기 링크 제공

  First Detection of Mycobacterium tuberculosis Clinical Isolates Harboring I491F Borderline Resistance rpoB Mutation in Myanmar (Antimicrobial Agents and Chemotherapy,2022)	초록보기
  Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3 months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trial(Trials, 2022)	초록보기
  Activation of the SigE-SigB signaling pathway by inhibition of the respiratory electron transport chain and its effect on rifampicin tolerance in Mycobacterium smegmatis (Journal of Microbiology,2022)	초록보기
  Impact of revised definitions for extensively drug-resistant TB on disease classification (International Journal of Tuberculosis and Lung, 2022)	초록보기

  해당 관련 논문목록과 초록보기 링크 제공

  Metabolite profiling of serum form patients with tuberculosis (Microbiology and Biotechnology Letters, 2021)	초록보기
  Spoligotype variation of Mycobacterium tuberculosis strains prevailing in Korea (Canadian Journal of Infectious Diseases and Medical Microbiology, 2021)	초록보기